Reasons for missing antiretroviral therapy: Results from a multi-country study in Tanzania, Uganda, and Zambia

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Koole, Olivier ^a,b   Denison, Julie A ^c,d   Menten, Joris ^b   Tsui, Sharon ^c,d   Wabwire Mangen, Fred ^e   Kwesigabo, Gideon ^f   Mulenga, Modest ^g   Auld, Andrew ^h   Agolory, Simon ^h   Mukadi, Ya Diul ^c   Van Praag, Eric ^c   Torpey, Kwasi ^c   Williams, Seymour ^h   Kaplan, Jonathan ^h   Zee, Aaron ^h   Bangsberg, David R ^i,j   Colebunders, Robert ^b,k  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c FAMILY HEALTH INTERNATIONAL   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^f MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^g TROPICAL DISEASES RESEARCH CENTRE   (Zambia)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^j HARVARD MEDICAL SCHOOL   (United States)

^k UNIVERSITY OF ANTWERP   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; STAVUDINE;

ADULT; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; DISEASE ASSOCIATION; FEMALE; FOOD INSECURITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT PARTICIPATION; RISK FACTOR; SELF REPORT; SEX DIFFERENCE; SYMPTOM ASSESSMENT; TANZANIA; UGANDA; ZAMBIA; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; MIDDLE AGED; MULTICENTER STUDY; PATHOGENICITY; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; VIROLOGY;

ADULT; ANTI-RETROVIRAL AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT COMPLIANCE; TANZANIA; UGANDA; ZAMBIA;

EID: 84958225322     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147309     Document Type: Article

References (53)

1. UNAIDS. The gap report 2014. 2014. Available: http://www.unaids.org/sites/default/files/en/media/ unaids/contentassets/documents/unaidspublication/2014/UNAIDS-Gap-report-en.pdf. Accessed 22 July 2015.
2. UNAIDS. Ambitious treatment targets: writing the final chapter on the AIDS epidemic. 2014. Available: http://www.unaids.org/sites/default/files/media-asset/JC2670-UNAIDS-Treatment-Targets-en.pdf. Accessed 22 July 2015.
3. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011 Aug 11; 365(6):493-505. doi: 10. 1056/NEJMoa1105243 PMID: 21767103
4. Loutfy MR, Wu W, Letchumanan M, Bondy L, Antoniou T, Margolese S, et al. Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy. PLOS ONE 2013; 8(2):e55747. Available: http://journals.plos.org/ plosone/article?id=10.1371/journal.pone.0055747 Accessed: 2015 July 22. doi: 10.1371/journal.pone. 0055747 PMID: 23418455
5. McMahon JH, Elliott JH, Bertagnolio S, Kubiak R, Jordan MR. Viral suppression after 12 months of antiretroviral therapy in low-and middle-income countries: a systematic review. Bull World Health Organ 2013 May 1; 91(5):377-385E. Available: http://www.who.int/bulletin/volumes/91/5/12-112946.pdf. Accessed 22 July 2015. doi: 10.2471/BLT.12.112946 PMID: 23678201
6. Hogg RS, Heath K, Bangsberg D, Yip B, Press N, O'Shaughnessy MV, et al. Intermittent use of triplecombination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS 2002 May 3; 16(7):1051-8. PMID: 11953472
7. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis 2000 Jun; 30 Suppl 2:S171-S176. PMID: 10860902
8. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLOS Med 2006 Nov; 3(11):e438. Available: http://www.plosmedicine.org/article/Related/info:doi/10.1371/journal. pmed.0030438. Accessed 22 July 2015. PMID: 17121449
9. Denison JA, Koole O, Tsui S, Menten J, Torpey K, van PE, et al. Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia. AIDS 2015 Jan 28; 29(3):361-71. doi: 10.1097/QAD.0000000000000543 PMID: 25686684
10. Koole O, Tsui S, Wabwire-Mangen F, Kwesigabo G, Menten J, Mulenga M, et al. Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia. Trop Med Int Health 2014 Dec; 19(12):1397-410. doi: 10.1111/tmi.12386 PMID: 25227621
11. Kalichman SC, Simbayi LC, Cloete A, Mthembu PP, Mkhonta RN, Ginindza T (2009) Measuring AIDS stigmas in people living with HIV/AIDS: the Internalized AIDS-Related Stigma Scale. AIDS Care 21: 87-93. doi: 10.1080/09540120802032627 PMID: 19085224
12. Kaaya SF, Fawzi MC, Mbwambo JK, Lee B, Msamanga GI, FawziW(2002) Validity of the Hopkins Symptom Checklist-25 amongst HIV-positive pregnant women in Tanzania. Acta Psychiatr Scand 106: 9-19. PMID: 12100343
13. Broadhead WE, Gehlbach SH, de Gruy FV, Kaplan BH (1988) The Duke-UNC Functional Social Support Questionnaire. Measurement of social support in family medicine patients. Med Care 26: 709-723. PMID: 3393031
14. Samet JH, Phillips SJ, Horton NJ, Traphagen ET, Freedberg KA (2004) Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire. AIDS Res Hum Retroviruses 20: 151-155. PMID: 15018702
15. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000 Jun; 12(3):255-66. PMID: 10928201
16. Justice AC, Holmes W, Gifford AL, Rabeneck L, Zackin R, Sinclair G, et al. Development and validation of a self-completed HIV symptom index. J Clin Epidemiol 2001 Dec; 54 Suppl 1:S77-S90. PMID: 11750213
17. Oyugi JH, Byakika-Tusiime J, Ragland K, Laeyendecker O, Mugerwa R, Kityo C, et al. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS 2007 May 11; 21(8):965-71. PMID: 17457090
18. Genberg BL, Wilson IB, Bangsberg DR, Arnsten J, Goggin K, Remien RH, et al. Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America. AIDS 2012 Jul 17; 26 (11):1415-23. doi: 10.1097/QAD.0b013e328354bed6 PMID: 22767342
19. Bhat VG, Ramburuth M, Singh M, Titi O, Antony AP, Chiya L, et al. Factors associated with poor adherence to anti-retroviral therapy in patients attending a rural health centre in South Africa. Eur J Clin Microbiol Infect Dis 2010 Aug; 29(8):947-53. doi: 10.1007/s10096-010-0949-4 PMID: 20467769
20. Unge C, Sodergard B, Marrone G, Thorson A, Lukhwaro A, Carter J, et al. Long-term adherence to antiretroviral treatment and program drop-out in a high-risk urban setting in sub-Saharan Africa: a prospective cohort study. PLOS ONE 2010; 5(10):e13613. Available: http://journals.plos.org/plosone/article? id=10.1371/journal.pone.0013613 Accessed: 2015 July 22. doi: 10.1371/journal.pone.0013613 PMID: 21049045
21. Barfod TS, Sorensen HT, Nielsen H, Rodkjaer L, Obel N. 'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence. HIV Med 2006 Jul; 7(5):285-90. PMID: 16945072
22. Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet 2010 Nov 27; 376(9755):1838-45. doi: 10.1016/S0140-6736(10)61997-6 PMID: 21071074
23. Roux P, Kouanfack C, Cohen J, Marcellin F, Boyer S, Delaporte E, et al. Adherence to antiretroviral treatment in HIV-positive patients in the Cameroon context: promoting the use of medication reminder methods. J Acquir Immune Defic Syndr 2011 Jul 1; 57 Suppl 1:S40-S43. doi: 10.1097/QAI. 0b013e318222b5c2 PMID: 21857285
24. Finitsis DJ, Pellowski JA, Johnson BT. Text message intervention designs to promote adherence to antiretroviral therapy (ART): a meta-analysis of randomized controlled trials. PLOS ONE 2014; 9(2): e88166. Available: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0088166. Accessed 22 July 2015. doi: 10.1371/journal.pone.0088166 PMID: 24505411
25. Mills EJ, Lester R, Thorlund K, Lorenzi M, Muldoon K. Interventions to promote adherence to antiretroviral therapy in Africa: a network meta-analysis. Lancet HIV 2014 Dec; 1(3):e104-e111. doi: 10.1016/ S2352-3018(14)00003-4 PMID: 26424119
26. Thirumurthy H, Lester RT. M-health for health behaviour change in resource-limited settings: applications to HIV care and beyond. Bull World Health Organ 2012 May 1; 90(5):390-2. Available: http:// www.who.int/bulletin/volumes/90/5/11-099317/en/. Accessed 22 July 2015. doi: 10.2471/BLT.11. 099317 PMID: 22589574
27. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach 2013.2013. Available: http://apps.who.int/iris/ bitstream/10665/85321/1/9789241505727-eng.pdf?ua=1. Accessed 22 July 2015.
28. Rodrigues R, Bogg L, Shet A, Kumar DS, De CA. Mobile phones to support adherence to antiretroviral therapy: what would it cost the Indian National AIDS Control Programme? J Int AIDS Soc 2014; 17:19036. Available: http://www.jiasociety.org/index.php/jias/article/view/19036/3934. Accessed 22 July 2015. doi: 10.7448/IAS.17.1.19036 PMID: 25186918
29. Martinez P, Tsai AC, Muzoora C, Kembabazi A, Weiser SD, Huang Y, et al. Reversal of the Kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans. J Acquir Immune Defic Syndr 2014 Apr 1; 65(4):456-62. doi: 10.1097/QAI.0000000000000062 PMID: 24220289
30. Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care 2007 May; 19(5):658-65. PMID: 17505927
31. Musumari PM, Feldman MD, Techasrivichien T, Wouters E, Ono-Kihara M, Kihara M. "If I have nothing to eat, I get angry and push the pills bottle away from me": A qualitative study of patient determinants of adherence to antiretroviral therapy in the Democratic Republic of Congo. AIDS Care 2013; 25 (10):1271-7. doi: 10.1080/09540121.2013.764391 PMID: 23383757
32. Musumari PM, Wouters E, Kayembe PK, Kiumbu NM, Mbikayi SM, Suguimoto SP, et al. Food insecurity is associated with increased risk of non-adherence to antiretroviral therapy among HIV-infected adults in the Democratic Republic of Congo: a cross-sectional study. PLOS ONE 2014; 9(1):e85327. Available: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085327. Accessed 22 July 2015. doi: 10.1371/journal.pone.0085327 PMID: 24454841
33. Singer AW, Weiser SD, McCoy SI. Does Food Insecurity Undermine Adherence to Antiretroviral Therapy? A Systematic Review. AIDS Behav 2014 Aug 6.
34. Weiser SD, Fernandes KA, Brandson EK, Lima VD, Anema A, Bangsberg DR, et al. The association between food insecurity and mortality among HIV-infected individuals on HAART. J Acquir Immune Defic Syndr 2009 Nov 1; 52(3):342-9. doi: 10.1097/QAI.0b013e3181b627c2 PMID: 19675463
35. Weiser SD, Palar K, Frongillo EA, Tsai AC, Kumbakumba E, Depee S, et al. Longitudinal assessment of associations between food insecurity, antiretroviral adherence and HIV treatment outcomes in rural Uganda. AIDS 2014 Jan 2; 28(1):115-20. doi: 10.1097/01.aids.0000433238.93986.35 PMID: 23939234
36. Cantrell RA, Sinkala M, Megazinni K, Lawson-Marriott S, Washington S, Chi BH, et al. A pilot study of food supplementation to improve adherence to antiretroviral therapy among food-insecure adults in Lusaka, Zambia. J Acquir Immune Defic Syndr 2008 Oct 1; 49(2):190-5. doi: 10.1097/QAI. 0b013e31818455d2 PMID: 18769349
37. Mamlin J, Kimaiyo S, Lewis S, Tadayo H, Jerop FK, Gichunge C, et al. Integrating nutrition support for food-insecure patients and their dependents into an HIV care and treatment program in Western Kenya. Am J Public Health 2009 Feb; 99(2):215-21. doi: 10.2105/AJPH.2008.137174 PMID: 19059851
38. Yager JE, Kadiyala S, Weiser SD. HIV/AIDS, food supplementation and livelihood programs in Uganda: a way forward? PLOS ONE 2011; 6(10):e26117. Available: http://journals.plos.org/plosone/ article?id=10.1371/journal.pone.0026117. Accessed 22 July 2015. doi: 10.1371/journal.pone.0026117 PMID: 22022530
39. UNAIDS. The Cities Report. 2014. Available: http://www.unaids.org/sites/default/files/media-asset/ JC2687-TheCitiesReport-en.pdf. Accessed 22 July 2015.
40. Voeten HA, Vissers DC, Gregson S, Zaba B, White RG, de Vlas SJ, et al. Strong association between in-migration and HIV prevalence in urban sub-Saharan Africa. Sex Transm Dis 2010 Apr; 37(4):240-3. doi: 10.1097/OLQ.0b013e3181c3f2d0 PMID: 19959971
41. Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N, Weiser SD. Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study. AIDS Behav 2010 Aug; 14(4):778-84. doi: 10.1007/s10461-009-9533-2 PMID: 19283464
42. Koole O, Houben RM, Mzembe T, Van Boeckel TP, Kayange M, Jahn A, et al. Improved retention of patients starting antiretroviral treatment in Karonga District, northern Malawi, 2005-2012. J Acquir Immune Defic Syndr 2014 Sep 1; 67(1):e27-e33. doi: 10.1097/QAI.0000000000000252 PMID: 24977375
43. Rasschaert F, Telfer B, Lessitala F, Decroo T, Remartinez D, Biot M, et al. A qualitative assessment of a community antiretroviral therapy group model in tete, mozambique. PLOS ONE 2014; 9(3):e91544. Available: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0091544. Accessed 22 July 2015. doi: 10.1371/journal.pone.0091544 PMID: 24651523
44. Duran S, Spire B, Raffi F, Walter V, Bouhour D, Journot V, et al. Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clin Trials 2001 Jan; 2(1):38-45. PMID: 11590513
45. Al-Dakkak I, Patel S, McCann E, Gadkari A, Prajapati G, Maiese EM. The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy: a systematic review and metaanalysis. AIDS Care 2013; 25(4):400-14. doi: 10.1080/09540121.2012.712667 PMID: 22908886
46. Bonfanti P, Valsecchi L, Parazzini F, Carradori S, Pusterla L, Fortuna P, et al. Incidence of adverse reactions in HIV patients treated with protease inhibitors: a cohort study. Coordinamento Italiano Studio Allergia e Infezione da HIV (CISAI) Group. J Acquir Immune Defic Syndr 2000 Mar 1; 23(3):236-45. PMID: 10839659
47. Sithinamsuwan P, Punthanamongkol S, Valcour V, Onsanit S, Nidhinandana S, Thitivichianlert S, et al. Frequency and characteristics of HIV-associated sensory neuropathy among HIV patients in Bangkok, Thailand. J Acquir Immune Defic Syndr 2008 Dec 1; 49(4):456-8. doi: 10.1097/QAI. 0b013e318186eb03 PMID: 19011422
48. Sacktor N, Nakasujja N, Skolasky RL, Robertson K, Musisi S, Ronald A, et al. Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda. Neurology 2009 Jan 13; 72 (2):165-70. doi: 10.1212/01.wnl.0000339042.96109.86 PMID: 19139369
49. Nakimuli-Mpungu E, Bass JK, Alexandre P, Mills EJ, Musisi S, Ram M, et al. Depression, alcohol use and adherence to antiretroviral therapy in sub-Saharan Africa: a systematic review. AIDS Behav 2012 Nov; 16(8):2101-18. doi: 10.1007/s10461-011-0087-8 PMID: 22116638
50. WHO. mhGAP: Mental Health Gap Action Programme. 2008. Available: http://whqlibdoc.who.int/ publications/2008/9789241596206-eng.pdf?ua=1. Accessed 22 July 2015.
51. Sarna A, Pujari S, Sengar AK, Garg R, Gupta I, Dam J (2008) Adherence to antiretroviral therapy & its determinants amongst HIV patients in India. Indian J Med Res 127: 28-36. PMID: 18316850
52. Haubrich RH, Little SJ, Currier JS, Forthal DN, Kemper CA, Beall GN, Johnson D, Dube MP, Hwang JY, McCutchan JA (1999) The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS 13: 1099-1107. PMID: 10397541
53. Nachega JB, Trotta MP, Nelson M, Ammassari A. Impact of metabolic complications on antiretroviral treatment adherence: clinical and public health implications. Curr HIV /AIDS Rep 2009 Aug; 6(3):121-9. PMID: 19589297